Nuvation Bio Inc.
Heterocyclic compounds as kinase inhibitors
Last updated:
Abstract:
Heterocyclic compounds of Formula (J) as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
15 Feb 2019
Issue date:
16 Nov 2021